|
US6407082B1
(en)
*
|
1996-09-13 |
2002-06-18 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a vitamin D compound
|
|
US6551611B2
(en)
*
|
1995-09-28 |
2003-04-22 |
Schering Aktiengesellschaft |
Hormone replacement therapy method
|
|
US6034074A
(en)
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
|
US6511970B1
(en)
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
|
US6028064A
(en)
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
|
AU9259598A
(en)
*
|
1997-07-08 |
1999-02-08 |
Gist-Brocades B.V. |
Topical application of a combination of benzoyl peroxide and a second active ingredient
|
|
AU2005201151B2
(en)
*
|
1999-03-30 |
2008-01-10 |
Jencap Research Ltd |
Low dose estrogen interrupted hormone replacement therapy
|
|
CA2267743C
(en)
|
1999-03-30 |
2011-07-26 |
Robert F. Casper |
Low dose estrogen interrupted hormone replacement therapy
|
|
DK1380301T3
(da)
*
|
1999-08-31 |
2009-04-20 |
Bayer Schering Pharma Ag |
Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
|
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
|
EP2305267A3
(en)
*
|
1999-08-31 |
2011-08-17 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
|
|
US20040191276A1
(en)
*
|
1999-11-30 |
2004-09-30 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
AU2001225413B2
(en)
*
|
2000-01-18 |
2005-06-23 |
Bayer Schering Pharma Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
US20020132801A1
(en)
*
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1251855A1
(en)
*
|
2000-01-28 |
2002-10-30 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
|
US20050113351A1
(en)
*
|
2000-03-21 |
2005-05-26 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US20040176336A1
(en)
*
|
2000-03-21 |
2004-09-09 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
CA2418135C
(en)
*
|
2000-08-03 |
2011-09-20 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
DE10045380A1
(de)
*
|
2000-09-14 |
2002-04-04 |
Schering Ag |
Verfahren zur Kontrazeption und dessen Darreichungsform
|
|
US20040172169A1
(en)
*
|
2001-03-02 |
2004-09-02 |
Curtis Wright |
Method and apparatus for compouding individualized dosege forms
|
|
WO2002074315A1
(de)
*
|
2001-03-21 |
2002-09-26 |
Schering Aktiengesellschaft |
Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
|
|
US7455656B2
(en)
*
|
2001-07-26 |
2008-11-25 |
Langeler Gerard E |
Pill delivery system
|
|
WO2003082299A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Jencap Research Ltd. |
Improved hormone replacement therapy
|
|
BR0309780A
(pt)
*
|
2002-04-26 |
2005-03-22 |
Schering Aktiengellschaft |
Tratamento da hipertensão em mulheres recebendo terapia de reposição hormonal
|
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
|
US7786101B2
(en)
*
|
2002-11-05 |
2010-08-31 |
Bayer Schering Pharma Ag |
Cardiovascular protection using anti-aldosteronic progestins
|
|
US6669390B1
(en)
|
2002-11-22 |
2003-12-30 |
John J. Porter |
Breath freshener with mouthwash atomizer
|
|
US7354598B2
(en)
*
|
2002-12-20 |
2008-04-08 |
Kimberly-Clark Worldwide, Inc. |
Packaging two different substrates
|
|
US7858607B2
(en)
*
|
2003-03-14 |
2010-12-28 |
Mamchur Stephen A |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
|
|
US7785584B2
(en)
*
|
2003-08-13 |
2010-08-31 |
Healthpoint, Ltd. |
Ointment wound spray
|
|
CA2538856C
(en)
*
|
2003-10-10 |
2010-06-29 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
US7293738B2
(en)
*
|
2003-11-26 |
2007-11-13 |
Kimberly-Clark Worldwide, Inc. |
Freestanding dispenser for dispensing two different substrates
|
|
US20050222106A1
(en)
*
|
2004-04-01 |
2005-10-06 |
Stefan Bracht |
Drospirenone-containing preparations for transdermal use
|
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
US20060040904A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Ahmed Salah U |
Vaginal cream compositions, kits thereof and methods of using thereof
|
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
US7537139B2
(en)
*
|
2005-05-27 |
2009-05-26 |
Henkel Corporation |
Dual chamber piston pressure pack dispenser system
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
JP2009501722A
(ja)
*
|
2005-07-15 |
2009-01-22 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ドロスピレノン含有経皮用薬剤供給装置及びその供給方法
|
|
WO2007076144A2
(en)
*
|
2005-12-27 |
2007-07-05 |
Duramed Pharmaceuticals, Inc. |
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
|
|
US7476291B2
(en)
*
|
2006-09-28 |
2009-01-13 |
Lam Research Corporation |
High chamber temperature process and chamber design for photo-resist stripping and post-metal etch passivation
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
US8658628B2
(en)
*
|
2009-06-18 |
2014-02-25 |
Karan Y. Baucom |
Hormone delivery system and method
|
|
US9795617B2
(en)
|
2009-06-18 |
2017-10-24 |
Baucom Institute for Longevity and Life Enhancement, Inc. |
Hormone delivery system and method
|
|
BR112013028171A2
(pt)
|
2011-05-02 |
2020-05-12 |
Mouse Trap Design, Llc |
Dispositivo para misturar uma pluralidade de fluidos para formular uma mistura e para dispensar a mistura
|
|
CA2745320A1
(en)
*
|
2011-07-06 |
2013-01-06 |
Duoject Medical Systems Inc. |
Reconstitution device
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
EP2782584B1
(en)
|
2011-11-23 |
2021-06-09 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US20150122837A1
(en)
|
2013-11-07 |
2015-05-07 |
Mouse Trap Design, Llc |
Mixing and dispensing device
|
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
EP3156349B1
(en)
*
|
2015-10-16 |
2018-07-04 |
Fontem Holdings 1 B.V. |
Mixing bottle
|
|
US10184818B2
(en)
|
2015-11-12 |
2019-01-22 |
Nodari Rizun |
Device and method for dispensing paste-like or sticky nutritional substance
|
|
US9903747B2
(en)
*
|
2015-11-12 |
2018-02-27 |
Nodari Rizun |
Device and method for dispersing paste-like or sticky nutritional substance in a fluid
|
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
CN108310608B
(zh)
*
|
2018-02-02 |
2020-07-31 |
韩明辉 |
一种医疗康复护理用涂药器
|
|
US10285998B1
(en)
|
2018-04-04 |
2019-05-14 |
The Menopause Method, Inc. |
Composition and method to aid in hormone replacement therapy
|
|
EP3833631A4
(en)
*
|
2018-08-10 |
2022-04-20 |
Azura Ophthalmics Ltd |
DISPENSER FOR ACCURATE EXTRACTION OF A SEMI-SOLID PRODUCT
|
|
US11382400B2
(en)
|
2018-08-10 |
2022-07-12 |
Go Products Co. |
Material applicator
|
|
CN111038860A
(zh)
*
|
2018-10-12 |
2020-04-21 |
元盛生医电子股份有限公司 |
容器结构
|
|
JP7315727B2
(ja)
*
|
2019-07-09 |
2023-07-26 |
ザ プロクター アンド ギャンブル カンパニー |
多組成物製品ディスペンサ
|
|
EP4087655A4
(en)
|
2020-01-10 |
2024-02-21 |
Azura Ophthalmics Ltd |
INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|